Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
April 6, 2020 Cover
Volume 98, Issue 13
Artificial intelligence is helping us find novel, useful molecules. For the field to really take off, though, these tools will need to be accessible to the wider chemistry community
Cover image:This tree diagram depicts all 1.87 million compounds in the ChEMBL database.
Credit: Jean-Louis Reymond
Exploring chemical space: Can AI take us where no human has gone before?
Artificial intelligence is helping us find novel, useful molecules. For the field to really take off, though, these tools will need to be accessible to the wider chemistry community
Chemistry faculty cope with coronavirus shutdowns
With university labs shuttered by COVID-19, chemistry faculty are getting a crash course in how to stay productive
Grad students tell of the coronavirus’s impact
Delayed postdoc opportunities. Canceled commencement. Graduate students in chemistry describe how the COVID-19 pandemic has affected their work and lives
-
Jen Heemstra on building your resilience
C&EN advice columnist offers 4 tips on adapting to times of uncertainty
-
What can initial remdesivir data tell us about tackling COVID-19?
Gilead Sciences’ antiviral is in multiple late-stage trials to treat coronavirus infections. Don’t expect a home run, say infectious disease experts
-
Meet Sheng Ding, who is tackling COVID-19 as director of China’s Global Health Drug Discovery Institute
The chemist wants the Gates Foundation–backed institute to share its expertise during the coronavirus pandemic and advocate for public health
ADVERTISEMENT
Science Concentrates
Coronavirus starts to weigh on industry
Auto manufacturing is the first sector to halt demand for chemicals
Business & Policy Concentrates
ADVERTISEMENT
Job listings
- SUNY Buffalo State: Assistant Professor in Chemistry
- Rosetta Commons: RaMP Postbac Fellowship: Training Program in Biomolecular Structure Prediction and Design
- Johns Hopkins University: REU: Program in Computational Biomolecular Structure & Design
- Harvard University: Tenure Track Professor in Quantum Science and Engineering